Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 241-246

  Ciarla, M V ^a   Bocciarelli, A ^a   Di Gregorio, S ^a   Tordi, A ^a   Cotroneo, P ^b   Marra, G ^b   Ghirlanda, G ^b   Strom, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anticardiolipin; Autoantibodies; Diabetes; Endothelin 1; Endothelium

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; ELASTASE; ENDOTHELIN 1; FIBRONECTIN; IMMUNOGLOBULIN G; INSULIN; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; ANTIBODY PRODUCTION; ARTERY ENDOTHELIUM; ARTICLE; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM LESION; FEMALE; HUMAN; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; VARIANCE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; FIBRONECTINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 0034910813     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00440-3     Document Type: Article

References (35)

1. Postprandial glucose and vascular disease
2. Immune system activation follows inflammation in unstable angina: Pathogenetic implications
3. Production of C-reactive protein and risk of coronary events in stable and unstable angina
4. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease
5. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
6. Endothelins
7. Modification of shear modulus and creep compliance of fibrin clots by fibronectin
8. Interaction of fibronectin with its receptor on platelets
9. Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets
10. Pathogenesis of thrombosis
11. Anticardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: Increased prevalence and relation to vascular complications
12. Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: Evidence for a prothrombotic state
13. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies
14. Insulin dependent diabetes mellitus hypothesis of autoimmunity
15. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
16. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum
17. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation
18. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
19. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets
20. Relationship between anti-phospholipid and anti-endothelial cell antibodies: Further characterization of the reactivity of resting and cytokine activated endothelial cells
21. Antiphospholipid antibodies activate vascular endothelial cells
22. Arterial disease and thrombosis in the antiphospholipid syndrome
23. Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome
24. Hypercoagulable states
25. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity - Studies in a thrombosis model
26. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study
27. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation
28. Inhibitors of immune complex induced human platelet aggregation and release in plasma
29. Complement: Chemistry and pathways
30. Additive effect of diabetes and systemic hypertension on the immune mechanism of atherosclerosis
31. Circulating immune complexes in patients with diabetes type 1 and 2
32. Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease
33. Vascular complications of diabetes mellitus: What role for phospholipid-binding antibodies?
34. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-protease inhibitor, and α2-macroglobulin
35. The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots